Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Macrophage inflammatory protein-1.

M Maurer1, E von Stebut

  • 1Department of Dermatology, University of Mainz, Langenbeckstr. 1, Mainz 55101, Germany. maurer@hautklinik.klinik.uni-mainz.de

The International Journal of Biochemistry & Cell Biology
|June 19, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multi-omics profiling of chronic immune-mediated skin diseases: SKINERGY protocol and strategic evaluation.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Ex Vivo Confocal Laser Scanning Microscopy for Real-Time Pattern and Single-Cell Analysis in Inflammatory Skin Diseases.

Experimental dermatology·2025
Same author

Impact of soil moisture content on urban tree evaporative cooling and human thermal comfort.

npj urban sustainability·2025
Same author

Delayed pressure urticaria affects chronic spontaneous urticaria treatment response: CURE insights.

European annals of allergy and clinical immunology·2025
Same author

Dermatologie (Heidelberg, Germany)·2025
Same author

Dermatologie (Heidelberg, Germany)·2025

Macrophage inflammatory protein (MIP)-1alpha and related CC chemokines are key in inflammation and immune responses. Their roles in conditions like asthma and arthritis are driving the development of new therapeutic antagonists.

Area of Science:

  • Immunology
  • Cell Biology
  • Biochemistry

Background:

  • Macrophage inflammatory protein (MIP)-1alpha, identified 15 years ago, is the first of four CC chemokine subfamily members.
  • These proteins, now named CCL3 (MIP-1alpha), CCL4 (MIP-1beta), CCL9/10 (MIP-1delta), and CCL15 (MIP-1gamma), are produced by various immune cells including macrophages, dendritic cells, and lymphocytes.
  • MIP-1 proteins signal through G-protein-coupled receptors CCR1, CCR3, and CCR5, which are expressed on lymphocytes and monocytes/macrophages.

Purpose of the Study:

  • To review the role of MIP-1 proteins in inflammation and homeostasis.
  • To highlight the therapeutic potential of MIP-1 protein antagonists in inflammatory diseases.

Main Methods:

  • Literature review of studies on MIP-1 proteins and their receptors.

Related Experiment Videos

  • Analysis of preclinical data from murine models of inflammatory diseases.

    • Main Results:

    • MIP-1 proteins exhibit both chemotactic, pro-inflammatory, and homeostatic effects.
    • Preclinical studies in models of asthma, arthritis, and multiple sclerosis show promising results for MIP-1 targeted therapies.
    • Development of potent CCR3 and CCR5 antagonists is underway, with some entering clinical trials.

    Conclusions:

    • MIP-1 proteins are crucial mediators in inflammatory and immune responses.
    • Targeting MIP-1 signaling pathways, particularly via CCR3 and CCR5 antagonists, represents a promising therapeutic strategy for inflammatory conditions.